Status:
RECRUITING
Roxadustat's Effect on Heart, Nutrition, and Inflammation in Hemodialysis Patients
Lead Sponsor:
Mansoura University
Conditions:
Kidney Failure, Chronic
Malnutrition-Inflammation Syndrome
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
Patients with kidney failure who require hemodialysis often suffer from anemia (low red blood cell count), heart and blood vessel problems, and a condition involving poor nutrition, inflammation, and ...
Detailed Description
Renal anemia is a frequent and significant complication in patients with end-stage kidney disease undergoing hemodialysis, affecting over 90% of this population. Anemia adversely impacts quality of li...
Eligibility Criteria
Inclusion
- Age of patient is more than 18.
- Patients who are willing to sign informed consent.
- Patients with ESKD on chronic hemodialysis for more than 3 months.
Exclusion
- Current pregnancy or lactation.
- Patients with pre-existing malignancy.
- Patients with psychosis or on hypnotics.
- Refuse to participate in the study.
- Known history of hematological disorders or other known causes for anemia other than CKD or dialysis.
- Patients with severe cardiovascular disease
Key Trial Info
Start Date :
April 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2025
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT06903559
Start Date
April 15 2025
End Date
November 1 2025
Last Update
May 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Urology and Nephrology Center, Mansoura University
Al Mansurah, Dakahliya, Egypt, 35111